92 results on '"DuBois JM"'
Search Results
2. First Result from the Alpha Magnetic Spectrometer on the International Space Station: Precision Measurement of the Positron Fraction in Primary Cosmic Rays of 0.5–350 GeV
- Author
-
Aguilar, M, Alberti, G, Alpat, B, Alvino, A, Ambrosi, G, Andeen, K, Anderhub, H, Arruda, L, Azzarello, P, Bachlechner, A, Barao, F, Baret, B, Barrau, A, Barrin, L, Bartoloni, A, Basara, L, Basili, A, Batalha, L, Bates, J, Battiston, R, Bazo, J, Becker, R, Becker, U, Behlmann, M, Beischer, B, Berdugo, J, Berges, P, Bertucci, B, Bigongiari, G, Biland, A, Bindi, V, Bizzaglia, S, de Boer, W, Bollweg, K, Bolmont, J, Borgia, B. Borsini, S, Boschini, MJ, Boudoul, G, Bourquin, M, Brun, P, Buenerd, M, Burger, J, Burger, W, Cadoux, F, Cai, XD, Capell, M, Casadei, D, Casaus, J, Cascioli, V, Castellini, G, Cernuda, I, Cervelli, F, Chae, MJ, Chang, YH, Chen, AI, Chen, CR, Chen, H, Cheng, GM, Chen, HS, Cheng, L, Chernoplyiokov, N, Chikanian, A, Choumilov, E, Choutko, V, Chung, CH, Clark, C, Clavero, R, Coignet, G, Commichau, V, Consolandi, C, Contin, A, Corti, C, Dios, MT, Costado Coste, B, Crespo, D, Cui, Z, Dai, M, Delgado, C, Della Torre, S, Demirkoz, B, Dennett, P, Derome, L, Di Falco, S, Diao, XH, Diago, A, Djambazov, L, Diaz, C, von Doetinchem, P, Du, WJ, Dubois, JM, Duperay, R, Duranti, M, D'Urso, D, Egorov, A, Eline, A, Eppling, FJ, Eronen, T, van Es, J, Esser, H, Falvard, A, Fiandrini, E, Fiasson, A, Finch, E, Fisher, P, Flood, K, Foglio, R, Fohey, M, Fopp, S, Fouque, N, Galaktionov, Y, Gallilee, M, Gallin Martel, L, Gallucci, G, Garcia, B, Garcia, J, Garcia Lopez, R, Garcia Tabares, L, Gargiulo, C, Gast, H, Gebauer, I, Gentile, S, Gillard, W, Giovacchini, F, Girard, L, Goglov, P, Gong, J, Goy Henningsen, C, Grandi, D, Graziani, M, Grechko, A, Gross, A, Guerri, I, de la Guia, C, Guo, KH, Habiby, M, Haino, S, Hauler, F, He, ZH, Heil, M, Heilig, J, Hermel, R, Hofer, H, Huang, ZC, Hungerford, W, Incagli, M, Ionica, M, Jacholkowska, A, Jang, WY, Jinchi, H, Jongmanns, M, Journet, L, Jungermann, L, Karpinski, W, Kim, GN, Kim, KS, Kirn, Th, Kossakowski, R, Koulemzine, A, Kounina, O, Kounine, A, Koutsenko, V, Krafczyk, MS, Laudi, E, Laurenti, G, Lauritzen, C, Lebedev, A, Lee, MW, Lee, SC, Leluc, C, Vargas, HL, Lepareur, V, Li, JQ, Li, Q, Li, TX, Li, W, Li, ZH, Lipari, P, Lin, CH, Liu, D, Liu, H, Lomtadze, T, Lu, YS, Lucidi, S, Luebelsmeyer, K, Luo, JZ, Lustermann, W, Lv, S, Madsen, J, Majka, R, Malinin, A, Mana, C, Marin, J, Martin, T, Martinez, G, Masciocchi, F, Masi, N, Maurin, D, McInturff, A, McIntyre, P, Menchaca Rocha, A, Meng, Q, Menichelli, M, Mereu, I, Millinger, M, Mo, DC, Molina, M, Mott, P, Mujunen, A, Natale, S, Nemeth, P, Ni, JQ, Nikonov, N, Nozzoli, F, Nunes, P, Obermeier, A, Oh, S, Oliva, A, Palmonari, F, Palomares, C, Paniccia, M, Papi, A, Park, WH, Pauluzzi, M, Pauss, F, Pauw, A, Pedreschi, E, Pereira, R, Perrin, E, Pierschel, G, Pilo, F, Piluso, A, Pizzolotto, C, Plyaskin, V, Pochon, J, Pohl, M, Poireau, V, Porter, S, Pouxe, J, Putze, A, Quadrani, L, Qi, XN, Rancoita, PG, Rapin, D, Ren, ZL, Ricol, JS, Riihonen, E, Rodriguez, I, Roeser, U, Rosier Lees, S, Rossi, L, Rozhkov, A, ROZZA, DAVIDE, Sabellek, A, Sagdeev, R, Sandweiss, J, Santos, B, Saouter, P, Sarchioni, M, Schael, S, Schinzel, D, Schmanau, M, Schwering, G, von Dratzig, AS, Scolieri, G, Seo, ES, Shan, BS, Shi, JY, Shi, YM, Siedenburg, T, Siedling, R, Son, D, Spada, F, Spinella, F, Steuer, M, Stiff, K, Sun, W, Sun, WH, Sun, XH, Tang, CP, Tang, XW, Tang, ZC, Tao, L, Tassan Viol, J, Ting, Samuel CC, Ting, SM, Titus, C, Tomassetti, N, Toral, F, Torsti, J, Tsai, JR, Tutt, JC, Ulbricht, J, Urban, T, Vagelli, V, Valente, E, Vannini, C, Valtonen, E, Trevino, MV, Vaurynovich, S, Vecchi, M, Vergain, M, Verlaat, B, Vescovi, C, Vialle, JP, Viertel, G, Volpini, G, Wang, D, Wang, NH, Wang, QL, Wang, RS, Wang, X, Wang, ZX, Wallraff, W, Weng, ZL, Willenbrock, M, Wlochal, M, Wu, H, Wu, KY, Wu, ZS, Xiao, WJ, Xie, S, Xiong, RQ, Xin, GM, Xu, NS, Xu, W, Yan, Q, Yang, J, Yang, M, Ye, QH, Yi, H, Yu, YJ, Yu, ZQ, Zeissler, S, Zhang, JG, Zhang, Z, Zhang, MM, Zheng, ZM, Zhuang, HL, Zhukov, V, Zichichi, A, Zuccon, P, Zurbach, C., BOELLA, GIULIANO FILIPPO, GERVASI, MASSIMO, PENSOTTI, SIMONETTA, PESSINA, GIANLUIGI EZIO, TACCONI, MAURO, M. Aguilar, G. Alberti, B. Alpat, A. Alvino, G. Ambrosi, K. Andeen, H. Anderhub, L. Arruda, P. Azzarello, A. Bachlechner, F. Barao, B. Baret, A. Barrau, L. Barrin, A. Bartoloni, L. Basara, A. Basili, L. Batalha, J. Bate, R. Battiston, J. Bazo, R. Becker, U. Becker, M. Behlmann, B. Beischer, J. Berdugo, P. Berge, B. Bertucci, G. Bigongiari, A. Biland, V. Bindi, S. Bizzaglia, G. Boella, W. de Boer, K. Bollweg, J. Bolmont, B. Borgia, S. Borsini, M. J. Boschini, G. Boudoul, M. Bourquin, P. Brun, M. Buénerd, J. Burger, W. Burger, F. Cadoux, X. D. Cai, M. Capell, D. Casadei, J. Casau, V. Cascioli, G. Castellini, I. Cernuda, F. Cervelli, M. J. Chae, Y. H. Chang, A. I. Chen, C. R. Chen, H. Chen, G. M. Cheng, H. S. Chen, L. Cheng, N. Chernoplyiokov, A. Chikanian, E. Choumilov, V. Choutko, C. H. Chung, C. Clark, R. Clavero, G. Coignet, V. Commichau, C. Consolandi, A. Contin, C. Corti, M. T. Costado Dio, B. Coste, D. Crespo, Z. Cui, M. Dai, C. Delgado, S. Della Torre, B. Demirkoz, P. Dennett, L. Derome, S. Di Falco, X. H. Diao, A. Diago, L. Djambazov, C. Díaz, P. von Doetinchem, W. J. Du, J. M. Duboi, R. Duperay, M. Duranti, D. D’Urso, A. Egorov, A. Eline, F. J. Eppling, T. Eronen, J. van E, H. Esser, A. Falvard, E. Fiandrini, A. Fiasson, E. Finch, P. Fisher, K. Flood, R. Foglio, M. Fohey, S. Fopp, N. Fouque, Y. Galaktionov, M. Gallilee, L. Gallin-Martel, G. Gallucci, B. García, J. García, R. García-López, L. García-Tabare, C. Gargiulo, H. Gast, I. Gebauer, S. Gentile, M. Gervasi, W. Gillard, F. Giovacchini, L. Girard, P. Goglov, J. Gong, C. Goy-Henningsen, D. Grandi, M. Graziani, A. Grechko, A. Gro, I. Guerri, C. de la Guía, K. H. Guo, M. Habiby, S. Haino, F. Hauler, Z. H. He, M. Heil, J. Heilig, R. Hermel, H. Hofer, Z. C. Huang, W. Hungerford, M. Incagli, M. Ionica, A. Jacholkowska, W. Y. Jang, H. Jinchi, M. Jongmann, L. Journet, L. Jungermann, W. Karpinski, G. N. Kim, K. S. Kim, Th. Kirn, R. Kossakowski, A. Koulemzine, O. Kounina, A. Kounine, V. Koutsenko, M. S. Krafczyk, E. Laudi, G. Laurenti, C. Lauritzen, A. Lebedev, M. W. Lee, S. C. Lee, C. Leluc, H. León Varga, V. Lepareur, J. Q. Li, Q. Li, T. X. Li, W. Li, Z. H. Li, P. Lipari, C. H. Lin, D. Liu, H. Liu, T. Lomtadze, Y. S. Lu, S. Lucidi, K. Lübelsmeyer, J. Z. Luo, W. Lustermann, S. Lv, J. Madsen, R. Majka, A. Malinin, C. Mañá, J. Marín, T. Martin, G. Martínez, F. Masciocchi, N. Masi, D. Maurin, A. McInturff, P. McIntyre, A. Menchaca-Rocha, Q. Meng, M. Menichelli, I. Mereu, M. Millinger, D. C. Mo, M. Molina, P. Mott, A. Mujunen, S. Natale, P. Nemeth, J. Q. Ni, N. Nikonov, F. Nozzoli, P. Nune, A. Obermeier, S. Oh, A. Oliva, F. Palmonari, C. Palomare, M. Paniccia, A. Papi, W. H. Park, M. Pauluzzi, F. Pau, A. Pauw, E. Pedreschi, S. Pensotti, R. Pereira, E. Perrin, G. Pessina, G. Pierschel, F. Pilo, A. Piluso, C. Pizzolotto, V. Plyaskin, J. Pochon, M. Pohl, V. Poireau, S. Porter, J. Pouxe, A. Putze, L. Quadrani, X. N. Qi, P. G. Rancoita, D. Rapin, Z. L. Ren, J. S. Ricol, E. Riihonen, I. Rodríguez, U. Roeser, S. Rosier-Lee, L. Rossi, A. Rozhkov, D. Rozza, A. Sabellek, R. Sagdeev, J. Sandwei, B. Santo, P. Saouter, M. Sarchioni, S. Schael, D. Schinzel, M. Schmanau, G. Schwering, A. Schulz von Dratzig, G. Scolieri, E. S. Seo, B. S. Shan, J. Y. Shi, Y. M. Shi, T. Siedenburg, R. Siedling, D. Son, F. Spada, F. Spinella, M. Steuer, K. Stiff, W. Sun, W. H. Sun, X. H. Sun, M. Tacconi, C. P. Tang, X. W. Tang, Z. C. Tang, L. Tao, J. Tassan-Viol, Samuel C. C. Ting, S. M. Ting, C. Titu, N. Tomassetti, F. Toral, J. Torsti, J. R. Tsai, J. C. Tutt, J. Ulbricht, T. Urban, V. Vagelli, E. Valente, C. Vannini, E. Valtonen, M. Vargas Trevino, S. Vaurynovich, M. Vecchi, M. Vergain, B. Verlaat, C. Vescovi, J. P. Vialle, G. Viertel, G. Volpini, D. Wang, N. H. Wang, Q. L. Wang, R. S. Wang, X. Wang, Z. X. Wang, W. Wallraff, Z. L. Weng, M. Willenbrock, M. Wlochal, H. Wu, K. Y. Wu, Z. S. Wu, W. J. Xiao, S. Xie, R. Q. Xiong, G. M. Xin, N. S. Xu, W. Xu, Q. Yan, J. Yang, M. Yang, Q. H. Ye, H. Yi, Y. J. Yu, Z. Q. Yu, S. Zeissler, J. G. Zhang, Z. Zhang, M. M. Zhang, Z. M. Zheng, H. L. Zhuang, V. Zhukov, A. Zichichi, P. Zuccon, C. Zurbach, Azzarello, Philipp, Bourquin, Maurice, Cadoux, Franck, Habiby Alaoui, Marion, Leluc, Catherine, Masciocchi, Florian, Paniccia, Mercedes, Perrin, Eric, Pohl, Martin, Rapin, Divic Jean, Saouter, Pierre, Metsähovi Radio Observatory, Aalto-yliopisto, Aalto University, OpenMETU, CERN [Genève], Centro de Investigaciones Energéticas Medioambientales y Tecnológicas [Madrid] (CIEMAT), Istituto Nazionale di Fisica Nucleare, Sezione di Perugia (INFN, Sezione di Perugia), Istituto Nazionale di Fisica Nucleare (INFN), Karlsruhe Institute of Technology (KIT), Institute for Theoretical Physics [ETH Zürich] (ITP), Department of Physics [ETH Zürich] (D-PHYS), Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology [Zürich] (ETH Zürich)- Eidgenössische Technische Hochschule - Swiss Federal Institute of Technology [Zürich] (ETH Zürich), RWTH Aachen University, Laboratoire de Physique Subatomique et de Cosmologie (LPSC), Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Institut Polytechnique de Grenoble - Grenoble Institute of Technology-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Joseph Fourier - Grenoble 1 (UJF)-Centre National de la Recherche Scientifique (CNRS), Laboratoire d'Annecy de Physique des Particules (LAPP), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Centre National de la Recherche Scientifique (CNRS), Massachusetts Institute of Technology (MIT), Laboratoire Univers et Particules de Montpellier (LUPM), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Montpellier 2 - Sciences et Techniques (UM2), Département de Physique Nucléaire et Corpusculaire [Genève] (DPNC), Université de Genève (UNIGE), Istituto Nazionale di Fisica Nucleare, Sezione di Bologna (INFN, Sezione di Bologna), Instituto de Astrofisica de Canarias (IAC), Instituto de Matematicas (UNAM), Universidad Nacional Autónoma de México (UNAM), Istituto Nazionale di Fisica Nucleare [Sezione di Roma 1] (INFN), Istituto Nazionale di Fisica Nucleare, INFN Sezione di Pisa (INFN Sezione di Pisa), Istituto Nazionale di Fisica Nucleare, Sezione di Milano (INFN), AMS, Aguilar, M, Alberti, G, Alpat, B, Alvino, A, Ambrosi, G, Andeen, K, Anderhub, H, Arruda, L, Azzarello, P, Bachlechner, A, Barao, F, Baret, B, Barrau, A, Barrin, L, Bartoloni, A, Basara, L, Basili, A, Batalha, L, Bates, J, Battiston, R, Bazo, J, Becker, R, Becker, U, Behlmann, M, Beischer, B, Berdugo, J, Berges, P, Bertucci, B, Bigongiari, G, Biland, A, Bindi, V, Bizzaglia, S, Boella, G, de Boer, W, Bollweg, K, Bolmont, J, Borgia, B., B, S, Boschini, M, Boudoul, G, Bourquin, M, Brun, P, Buenerd, M, Burger, J, Burger, W, Cadoux, F, Cai, X, Capell, M, Casadei, D, Casaus, J, Cascioli, V, Castellini, G, Cernuda, I, Cervelli, F, Chae, M, Chang, Y, Chen, A, Chen, C, Chen, H, Cheng, G, Cheng, L, Chernoplyiokov, N, Chikanian, A, Choumilov, E, Choutko, V, Chung, C, Clark, C, Clavero, R, Coignet, G, Commichau, V, Consolandi, C, Contin, A, Corti, C, Dios, M, Costado Coste, B, Crespo, D, Cui, Z, Dai, M, Delgado, C, Della Torre, S, Demirkoz, B, Dennett, P, Derome, L, Di Falco, S, Diao, X, Diago, A, Djambazov, L, Diaz, C, von Doetinchem, P, Du, W, Dubois, J, Duperay, R, Duranti, M, D'Urso, D, Egorov, A, Eline, A, Eppling, F, Eronen, T, van Es, J, Esser, H, Falvard, A, Fiandrini, E, Fiasson, A, Finch, E, Fisher, P, Flood, K, Foglio, R, Fohey, M, Fopp, S, Fouque, N, Galaktionov, Y, Gallilee, M, Gallin Martel, L, Gallucci, G, Garcia, B, Garcia, J, Garcia Lopez, R, Garcia Tabares, L, Gargiulo, C, Gast, H, Gebauer, I, Gentile, S, Gervasi, M, Gillard, W, Giovacchini, F, Girard, L, Goglov, P, Gong, J, Goy Henningsen, C, Grandi, D, Graziani, M, Grechko, A, Gross, A, Guerri, I, de la Guia, C, Guo, K, Habiby, M, Haino, S, Hauler, F, He, Z, Heil, M, Heilig, J, Hermel, R, Hofer, H, Huang, Z, Hungerford, W, Incagli, M, Ionica, M, Jacholkowska, A, Jang, W, Jinchi, H, Jongmanns, M, Journet, L, Jungermann, L, Karpinski, W, Kim, G, Kim, K, Kirn, T, Kossakowski, R, Koulemzine, A, Kounina, O, Kounine, A, Koutsenko, V, Krafczyk, M, Laudi, E, Laurenti, G, Lauritzen, C, Lebedev, A, Lee, M, Lee, S, Leluc, C, Vargas, H, Lepareur, V, Li, J, Li, Q, Li, T, Li, W, Li, Z, Lipari, P, Lin, C, Liu, D, Liu, H, Lomtadze, T, Lu, Y, Lucidi, S, Luebelsmeyer, K, Luo, J, Lustermann, W, Lv, S, Madsen, J, Majka, R, Malinin, A, Mana, C, Marin, J, Martin, T, Martinez, G, Masciocchi, F, Masi, N, Maurin, D, Mcinturff, A, Mcintyre, P, Menchaca Rocha, A, Meng, Q, Menichelli, M, Mereu, I, Millinger, M, Mo, D, Molina, M, Mott, P, Mujunen, A, Natale, S, Nemeth, P, Ni, J, Nikonov, N, Nozzoli, F, Nunes, P, Obermeier, A, Oh, S, Oliva, A, Palmonari, F, Palomares, C, Paniccia, M, Papi, A, Park, W, Pauluzzi, M, Pauss, F, Pauw, A, Pedreschi, E, Pensotti, S, Pereira, R, Perrin, E, Pessina, G, Pierschel, G, Pilo, F, Piluso, A, Pizzolotto, C, Plyaskin, V, Pochon, J, Pohl, M, Poireau, V, Porter, S, Pouxe, J, Putze, A, Quadrani, L, Qi, X, Rancoita, P, Rapin, D, Ren, Z, Ricol, J, Riihonen, E, Rodriguez, I, Roeser, U, Rosier Lees, S, Rossi, L, Rozhkov, A, Rozza, D, Sabellek, A, Sagdeev, R, Sandweiss, J, Santos, B, Saouter, P, Sarchioni, M, Schael, S, Schinzel, D, Schmanau, M, Schwering, G, von Dratzig, A, Scolieri, G, Seo, E, Shan, B, Shi, J, Shi, Y, Siedenburg, T, Siedling, R, Son, D, Spada, F, Spinella, F, Steuer, M, Stiff, K, Sun, W, Sun, X, Tacconi, M, Tang, C, Tang, X, Tang, Z, Tao, L, Tassan Viol, J, Ting, S, Titus, C, Tomassetti, N, Toral, F, Torsti, J, Tsai, J, Tutt, J, Ulbricht, J, Urban, T, Vagelli, V, Valente, E, Vannini, C, Valtonen, E, Trevino, M, Vaurynovich, S, Vecchi, M, Vergain, M, Verlaat, B, Vescovi, C, Vialle, J, Viertel, G, Volpini, G, Wang, D, Wang, N, Wang, Q, Wang, R, Wang, X, Wang, Z, Wallraff, W, Weng, Z, Willenbrock, M, Wlochal, M, Wu, H, Wu, K, Wu, Z, Xiao, W, Xie, S, Xiong, R, Xin, G, Xu, N, Xu, W, Yan, Q, Yang, J, Yang, M, Ye, Q, Yi, H, Yu, Y, Yu, Z, Zeissler, S, Zhang, J, Zhang, Z, Zhang, M, Zheng, Z, Zhuang, H, Zhukov, V, Zichichi, A, Zuccon, P, and Zurbach, C
- Subjects
[PHYS.ASTR.HE]Physics [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE] ,Astrophysics::High Energy Astrophysical Phenomena ,education ,Dark matter ,General Physics and Astronomy ,Electrons ,Cosmic ray ,ddc:500.2 ,Electron ,01 natural sciences ,and other elementary particle detectors ,cosmic ray detectors ,Nuclear physics ,Physics and Astronomy (all) ,Positron ,cosmic rays ,muon ,Neutrino ,0103 physical sciences ,Alpha Magnetic Spectrometer ,010306 general physics ,Anisotropy ,Physics ,Range (particle radiation) ,ta115 ,ta213 ,ta114 ,Cosmic rays, positron fraction, space experiments ,010308 nuclear & particles physics ,[SDU.ASTR.HE]Sciences of the Universe [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE] ,pion ,Observable ,energy spectra and interactions ,pion, and other elementary particle detectors ,ELECTRONS ,cosmic rays, dark matter ,Physics::Accelerator Physics ,High Energy Physics::Experiment ,Composition - Abstract
A precision measurement by the Alpha Magnetic Spectrometer on the International Space Station of the positron fraction in primary cosmic rays in the energy range from 0.5 to 350 GeV based on 6.8 x 10(6) positron and electron events is presented. The very accurate data show that the positron fraction is steadily increasing from 10 to similar to 250 GeV, but, from 20 to 250 GeV, the slope decreases by an order of magnitude. The positron fraction spectrum shows no fine structure, and the positron to electron ratio shows no observable anisotropy. Together, these features show the existence of new physical phenomena. DOI: 10.1103/PhysRevLett.110.141102
- Published
- 2013
3. Ethics education in MSN programs: a study of national trends.
- Author
-
Burkemper JE, DuBois JM, Lavin MA, Meyer GA, and McSweeney M
- Abstract
The aim of this study was to determine the manner in which master's of science in nursing programs, accredited by either the National League for Nursing Accrediting Commission or the Commission on Collegiate Nursing Education, conduct ethics education. A survey method was employed to obtain requisite data. Among the main variables investigated were: the percentage of programs that require a course with formal ethics content; the average number of class hours a program or track dedicates to ethics education; required and actual credentials of instructors who teach ethics; and objectives, topics, teaching methods, and grading methods of required courses with formal ethics content. Results indicated that most programs do not require instructors to have completed formal ethics training. In terms of content, few common trends exist and there are important gaps in clinical ethics topics. Comparisons between school of medicine ethics content reported in the literature and MSN ethics content reported in this study indicate that medical schools are more exacting of their students. The study concludes with a call for the establishment of guidelines or standards relevant to ethics content in MSN curricula in the United States. [ABSTRACT FROM AUTHOR]
- Published
- 2007
4. EXTENDED X-RAY-ABSORPTION FINE-STRUCTURE STUDY OF THE ANNEALING EFFECT ON GLASSY PD76B24 - COMPARISON WITH X-RAY-DIFFRACTION AND MODELING RESULTS
- Author
-
COCCO G, ENZO S, BALERNA A, DUBOIS JM, MOBILIO, Settimio, Cocco, G, Enzo, S, Balerna, A, Mobilio, Settimio, and Dubois, Jm
- Published
- 1987
5. Effects of dim-evening lighting optimised for geographical orientation versus standard lighting on mental health: protocol paper for a quasiexperimental study in a psychiatric hospital.
- Author
-
Volf C, Corell DD, Hansen TS, Dubois JM, Zeng X, Baandrup L, Petersen PM, and Martiny K
- Subjects
- Humans, Denmark, Circadian Rhythm physiology, Quality of Life, Sleep physiology, Male, Lighting, Mental Health, Hospitals, Psychiatric
- Abstract
Introduction: Research has provided novel insights into how light stimulates circadian rhythms through specialised retinal ganglion cells to the suprachiasmatic nucleus. In addition, there has been a revolution in light-emitting diode (LED) technology, leading to tunable LED light sources and lighting systems, enabling 24-hour dynamic light scenarios with bright blue-enriched short wavelength light during the day and dim evening light, stimulating the circadian system. These dynamic LED lighting systems are now being implemented at hospitals without adequate understanding of how it may affect the health and well-being of patients and staff., Methods and Analysis: An optimised dynamic LED lighting scenario is investigated at a newly built psychiatric hospital in Copenhagen. In the 12 months baseline period, a standard lighting scenario with dynamic colour temperature and fixed light intensity is investigated. In the following 12-month intervention period, a new DEL scenario is investigated, having dynamic colour temperature as well as dynamic light intensity with a higher daytime and lower evening-time melanopic daylight equivalent illuminance. This setting is furthermore adjusted for geographical orientation to compensate for differences in sunlight access in wintertime. The study uses a quasiexperimental design comparing patients admitted in the two study periods. Prior to each of the study periods, daylight and the contribution from the LED-lighting scenarios was measured. Patient sociodemographic and mental health data will be retrieved retrospectively from electronic medical records and by questionnaires administered in the two periods, evaluating lighting, noise, sleep quality and quality of life. Primary outcome is the proportion of patients receiving pro re nata medications. Secondary outcomes are the length of stay, sleep onset latency, sleep quality and quality of life., Ethics and Dissemination: No ethical issues are expected. The results will be disseminated through peer-reviewed international journal, lectures, posters and interviews., Trial Registration Number: NCT05868291., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
6. A training protocol compliance of 13% was observed in a research study of clinical research professionals.
- Author
-
Solomon ED, Mozersky J, Parsons MV, Baldwin K, Goodman M, and DuBois JM
- Subjects
- Humans, Informed Consent, Biomedical Research education, Female, Male, Guideline Adherence statistics & numerical data, Adult, Research Personnel education, Research Personnel statistics & numerical data
- Abstract
Objective: We attempted to conduct a randomized controlled trial of three different informed consent training formats to evaluate their effectiveness. We recruited 503 clinical research professionals, who received $50 for participation. Incidental findings showed unexpectedly low rates of compliance with completing the study training protocols, resulting in insufficient statistical power to test our original hypotheses. In this report, we conducted a secondary analysis of the data in which we characterize and evaluate the observed low compliance. This involved using literature on average reading times, speed-reading times, and video play speeds to calculate the timeframes required to complete the three training formats., Results: Only 13% of participants completed the training in a reasonable timeframe. Furthermore, only 46% of participants completed the training in the minimum possible timeframe. These findings lead us to ask whether online research training is effective, since no training can be effective if participants do not actually complete the training. Given extensive requirements for educational training among clinical research professionals, we feel the burden of proof is on training programs to demonstrate that they have positive effects., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
7. SGLT2i treatment during AKI and its association with major adverse kidney events.
- Author
-
Alcantar-Vallin L, Zaragoza JJ, Díaz-Villavicencio B, Hernandez-Morales K, Camacho-Guerrero JR, Perez-Venegas MA, Carmona-Morales EJ, Oseguera-Gonzalez AN, Murguia-Soto C, Chávez-Alonso G, Arredondo-Dubois JM, Orozco-Chan CE, Gómez-Fregoso JA, Rodríguez-García FG, Navarro-Blackaller G, Medina-González R, Martínez Gallardo-González A, Abundis-Mora GJ, Vega-Vega O, García-García G, and Chávez-Iñiguez JS
- Abstract
Background: The association between the administration of sodium-glucose cotransporter 2 inhibitors (SGLT2is) during acute kidney injury (AKI) and the incidence of major adverse kidney events (MAKEs) is not known., Methods: This retrospective cohort study included patients with AKI and compared the outcomes for those who were treated with SGLT2is during hospitalization and those without SGLT2i treatment. The associations of SGLT2i use with MAKEs at 10 and 30-90 days, each individual MAKE component, and the pre-specified patient subgroups were analyzed., Results: From 2021 to 2023, 374 patients were included in the study-316 without SGLT2i use and 58 with SGLT2i use. Patients who were treated with SGLT2is were older; had a greater prevalence of diabetes, hypertension, chronic heart failure, and chronic kidney disease; required hemodialysis less often; and presented stage 3 AKI less frequently than those who were not treated with SGLT2is. Logistic regression analysis with nearest-neighbor matching revealed that SGLT2i use was not associated with the risk of MAKE10 (OR 1.08 [0.45-2.56]) or with MAKE30-90 (OR 0.76 [0.42-1.36]). For death, the stepwise approach demonstrated that SGLT2i use was associated with a reduced risk (OR 0.08; 0.01-0.64), and no effect was found for kidney replacement therapy (KRT). The subgroups of patients who experienced a reduction in the risk of MAKEs in patients with AKI treated with SGLT2is were those older than 61 years, those with an eGFR >81, and those without a history of hypertension or DM ( p ≤ 0.05 for all)., Conclusion: The use of SGLT2is during AKI had no effect on short- or medium-term MAKEs, but some subgroups of patients may have experienced benefits from SGLT2i treatment., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Alcantar-Vallin, Zaragoza, Díaz-Villavicencio, Hernandez-Morales, Camacho-Guerrero, Perez-Venegas, Carmona-Morales, Oseguera-Gonzalez, Murguia-Soto, Chávez-Alonso, Arredondo-Dubois, Orozco-Chan, Gómez-Fregoso, Rodríguez-García, Navarro-Blackaller, Medina-González, Martínez Gallardo-González, Abundis-Mora, Vega-Vega, García-García and Chávez-Iñiguez.)
- Published
- 2024
- Full Text
- View/download PDF
8. Rationale and design of a double-blinded, randomized placebo-controlled trial of 40 Hz light neurostimulation therapy for depression (FELIX).
- Author
-
Sakalauskaitė L, Hansen LS, Dubois JM, Ploug Larsen M, Feijóo GM, Carstensen MS, Woznica Miskowiak K, Nguyen M, Harder Clemmensen LK, Petersen PM, and Martiny K
- Subjects
- Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Young Adult, Double-Blind Method, Electroencephalography methods, Gamma Rhythm physiology, Phototherapy methods, Treatment Outcome, Randomized Controlled Trials as Topic, Depressive Disorder, Major therapy
- Abstract
Background: Major depressive disorder (MDD) is a debilitating condition that affects more than 300 million people worldwide. Current treatments are based on a trial-and-error approach, and reliable biomarkers are needed for more informed and personalized treatment solutions. One of the potential biomarkers, gamma-frequency (30-80 Hz) brainwaves, are hypothesized to originate from the excitatory-inhibitory interaction between the pyramidal cells and interneurons. The imbalance between this interaction is described as a crucial pathological mechanism in neuropsychiatric conditions, including MDD, and the modulation of this pathological interaction has been investigated as a potential target. Previous studies attempted to induce gamma activity in the brain using rhythmic light and sound stimuli (GENUS - Gamma Entrainment Using Sensory stimuli) that resulted in neuroprotective effects in Alzheimer's disease (AD) patients and animal models. Here, we investigate the antidepressant, cognitive, and electrophysiological effects of the novel light therapy approach using 40 Hz masked flickering light for patients diagnosed with MDD., Methods and Design: Sixty patients with a current diagnosis of a major depressive episode will be enrolled in a randomized, double-blinded, placebo-controlled trial. The active treatment group will receive 40 Hz masked flickering light stimulation while the control group will receive continuous light matched in color temperature and brightness. Patients in both groups will get daily light treatment in their own homes and will attend four follow-up visits to assess the symptoms of depression, including depression severity measured by Hamilton Depression Rating Scale (HAM-D
17 ), cognitive function, quality of life and sleep, and electroencephalographic changes. The primary endpoint is the mean change from baseline to week 6 in depression severity (HAM-D6 subscale) between the groups.- Published
- 2024
- Full Text
- View/download PDF
9. Reproductive decision making in women with medical comorbidities: a qualitative study.
- Author
-
Kraus EM, Chavan NR, Whelan V, Goldkamp J, and DuBois JM
- Subjects
- Pregnancy, Humans, Female, Contraceptive Agents, Pregnancy Outcome, Decision Making, Contraception Behavior, Contraception, Pregnancy, Unplanned
- Abstract
Background: A growing number of reproductive-age women in the U.S. have chronic medical conditions, increasing their risk of perinatal morbidity and mortality. Still, they experience unintended pregnancies at similar rates to low-risk mothers. We have limited understanding of how these individuals consider decisions about pregnancy and contraceptive use. The purpose of this study was to understand factors that influence reproductive decision-making among pregnant women with chronic medical conditions., Methods: We conducted 28 semi-structured interviews with pregnant women with pre-existing medical conditions admitted to a tertiary maternal hospital to examine factors influencing reproductive decision making. Maternal demographic characteristics, medical history, and pregnancy outcome data were obtained through participant surveys and abstraction from electronic health records. Interview transcripts were coded and analyzed using Dedoose® with both deductive and inductive content analysis., Results: Out of 33 eligible participants, 30 consented to participate and 28 completed interviews. The majority of participants identified as black, Christian, made less than $23,000 yearly, and had a variety of preexisting medical conditions. Overarching themes included: 1) Perceived risks-benefits of pregnancy, 2) Perceived risks-benefits of birth control, 3) Determinants of contraceptive utilization, and 4) Perceived reproductive self-agency. Contraception was viewed as acceptable, but with concerning physical and psychological side effects. Although some considered pregnancy as a health threat, more experienced pregnancy as positive and empowering. Few planned their pregnancies., Conclusions: Preexisting health conditions did not significantly influence reproductive decision-making. Barriers to birth control use were generally based in patient value-systems instead of external factors. Interventions to improve uptake and use of birth control in this cohort should focus on improving care for chronic health conditions and influencing patient knowledge and attitudes toward contraception., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
10. Preliminary Exploration of Pseudo-CT-Based Attenuation Correction for Simultaneous PET/MRI Brain Imaging in Nonhuman Primates.
- Author
-
Yoo CH, DuBois JM, Wang L, Tang Y, Hou L, Xu H, Chen J, Liang SH, Izquierdo-Garcia D, and Wey HY
- Abstract
This study aimed to develop a template-based attenuation correction (AC) for the nonhuman primate (NHP) brain. We evaluated the effects of AC on positron emission tomography (PET) data quantification with two experimental paradigms by comparing the quantitative outcomes obtained using a segmentation-based AC versus template-based AC. Population-based atlas was generated from ten adult rhesus macaques. Bolus experiments using [
18 F]PF-06455943 and a bolus-infusion experiment using [11 C]OMAR were performed on a 3T Siemens PET/magnetic resonance-imaging (MRI). PET data were reconstructed with either μ map obtained from the segmentation-based AC or template-based AC. The standard uptake value (SUV), volume of distribution ( VT ), or percentage occupancy of rimonabant were calculated for [18 F]PF-06455943 and [11 C]OMAR PET, respectively. The leave-one-out cross-validation showed that the absolute percentage differences were 2.54 ± 2.86% for all region of interests. The segmentation-based AC had a lower SUV and VT (∼10%) of [18 F]PF-06455943 than the template-based method. The estimated occupancy was higher in the template-based method compared to the segmentation-based AC in the bolus-infusion study. However, future studies may be needed if a different reference tissue is selected for data quantification. Our template-based AC approach was successfully developed and applied to the NHP brain. One limitation of this study was that validation was performed by comparing two different MR-based AC approaches without validating against AC methods based on computed tomography (CT)., Competing Interests: The authors declare no competing financial interest., (© 2023 The Authors. Published by American Chemical Society.)- Published
- 2023
- Full Text
- View/download PDF
11. Palliative care in CADASIL: diagnosis is only the first step.
- Author
-
Aguilar-Fuentes V, Justo-Hernández D, Arredondo-Dubois JM, Ruiz-Sandoval JL, and Jiménez-Ruiz A
- Subjects
- Humans, Palliative Care, Diagnosis, Differential, Mutation, Magnetic Resonance Imaging, CADASIL diagnosis, CADASIL therapy
- Abstract
Competing Interests: The authors have no conflict of interest to declare.
- Published
- 2023
- Full Text
- View/download PDF
12. Exchanging words: Engaging the challenges of sharing qualitative research data.
- Author
-
DuBois JM, Mozersky J, Parsons M, Walsh HA, Friedrich A, and Pienta A
- Abstract
In January 2023, a new NIH policy on data sharing went into effect. The policy applies to both quantitative and qualitative research (QR) data such as data from interviews or focus groups. QR data are often sensitive and difficult to deidentify, and thus have rarely been shared in the United States. Over the past 5 y, our research team has engaged stakeholders on QR data sharing, developed software to support data deidentification, produced guidance, and collaborated with the ICPSR data repository to pilot the deposit of 30 QR datasets. In this perspective article, we share important lessons learned by addressing eight clusters of questions on issues such as where, when, and what to share; how to deidentify data and support high-quality secondary use; budgeting for data sharing; and the permissions needed to share data. We also offer a brief assessment of the state of preparedness of data repositories, QR journals, and QR textbooks to support data sharing. While QR data sharing could yield important benefits to the research community, we quickly need to develop enforceable standards, expertise, and resources to support responsible QR data sharing. Absent these resources, we risk violating participant confidentiality and wasting a significant amount of time and funding on data that are not useful for either secondary use or data transparency and verification.
- Published
- 2023
- Full Text
- View/download PDF
13. Engaging Adolescents in Using Online Patient Portals.
- Author
-
Sisk BA, Antes AL, Bereitschaft C, Enloe M, Lin S, Srinivas M, Bourgeois F, and DuBois JM
- Subjects
- Humans, Adolescent, Self-Management, Transition to Adult Care, Patient Portals, Access to Information
- Abstract
Importance: Many health care systems offer adolescents access to health information through online patient portals, but few studies have explored how to engage adolescents in using and benefiting from online portals., Objective: To determine how US children's hospitals have attempted to encourage adolescent portal use, barriers to engaging adolescents, and ideal future goals for engagement., Design, Setting, and Participants: This qualitative study performed structured qualitative interviews with informatics administrators from children's hospitals across the US between February and July 2022. Informatics administrators were employed by US health care systems that managed a children's hospital with at least 50 dedicated pediatrics beds. Data analysis was performed from November 2022 to January 2023., Main Outcomes and Measures: This study used thematic analysis of (1) current steps that health care systems had taken to engage adolescents in using their online patient portals and (2) barriers to engaging adolescents and ideal future goals and outcomes of engagement., Results: Among 58 total interviews with 65 informatics administrators who represented 63 hospitals across 58 health care systems, 6 themes of approaches to engaging adolescents in portal use were identified: (1) promoting and educating adolescents about portal enrollment, (2) establishing workflows to support enrollment, (3) seeking and incorporating feedback, (4) creating a culture or environment supporting engagement, (5) increasing portal utility, and (6) limited efforts. Barriers to engaging adolescents in portal use related to either (1) stakeholder investment, interest, and capabilities or (2) intersecting technical, ethical, and legal factors. Participants identified 4 ideal future efforts to engage adolescents: (1) develop adaptable private means of communication with adolescents, (2) use adolescent-centric user design, (3) enhance promotion and education about portal use, and (4) simplify and adapt workflows to encourage enrollment. Participants described 3 ideal outcomes of this future engagement: (1) provide education about current health, (2) prepare for transition to adulthood, and (3) improve digital health education of adolescents., Conclusions and Relevance: In this qualitative study of informatics administrators, children's hospitals across the US were found to have varying degrees of efforts to engage adolescents in using their portals. Most of these efforts focused on supporting adolescent enrollment, but fewer efforts focused on making the portal useful and interesting to adolescents.
- Published
- 2023
- Full Text
- View/download PDF
14. A Visual Interpretation Algorithm for Assessing Brain Tauopathy with 18 F-MK-6240 PET.
- Author
-
Seibyl JP, DuBois JM, Racine A, Collins J, Guo Q, Wooten D, Stage E, Cheng D, Gunn RN, Porat L, Whittington A, Kuo PH, Ichise M, Comley R, Martarello L, and Salinas C
- Subjects
- Humans, Cross-Sectional Studies, tau Proteins metabolism, Positron-Emission Tomography methods, Brain metabolism, Alzheimer Disease metabolism
- Abstract
In vivo characterization of pathologic deposition of tau protein in the human brain by PET imaging is a promising tool in drug development trials of Alzheimer disease (AD). 6-(fluoro-
18 F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine (18 F-MK-6240) is a radiotracer with high selectivity and subnanomolar affinity for neurofibrillary tangles that shows favorable nonspecific brain penetration and excellent kinetic properties. The purpose of the present investigation was to develop a visual assessment method that provides both an overall assessment of brain tauopathy and regional characterization of abnormal tau deposition. Methods:18 F-MK-6240 scans from 102 participants (including cognitively normal volunteers and patients with AD or other neurodegenerative disorders) were reviewed by an expert nuclear medicine physician masked to each participant's diagnosis to identify common patterns of brain uptake. This initial visual read method was field-tested in a separate, nonoverlapping cohort of 102 participants, with 2 additional naïve readers trained on the method. Visual read outcomes were compared with semiquantitative assessments using volume-of-interest SUV ratio. Results: For the visual read, the readers assessed 8 gray-matter regions per hemisphere as negative (no abnormal uptake) or positive (1%-25% of the region involved, 25%-75% involvement, or >75% involvement) and then characterized the tau binding pattern as positive or negative for evidence of tau and, if positive, whether brain uptake was in an AD pattern. The readers demonstrated agreement 94% of the time for overall positivity or negativity. Concordance on the determination of regional binary outcomes (negative or positive) showed agreement of 74.3% and a Fleiss κ of 0.912. Using clinical diagnosis as the ground truth, the readers demonstrated a sensitivity of 73%-79% and specificity of 91%-93%, with a combined reader-concordance sensitivity of 80% and specificity of 93%. The average SUV ratio in cortical regions showed a robust correlation with visually derived ratings of regional involvement ( r = 0.73, P < 0.0001). Conclusion: We developed a visual read algorithm for18 F-MK-6240 PET offering determination of both scan positivity and the regional degree of cortical involvement. These cross-sectional results show strong interreader concordance on both binary and regional assessments of tau deposition, as well as good sensitivity and excellent specificity supporting use as a tool for clinical trials., (© 2023 by the Society of Nuclear Medicine and Molecular Imaging.)- Published
- 2023
- Full Text
- View/download PDF
15. Barriers to Using Legally Authorized Representatives in Clinical Research with Older Adults.
- Author
-
Mozersky J, Solomon ED, Baldwin K, Wroblewski M, Parsons M, Goodman M, and DuBois JM
- Abstract
Background: Older adults are at increased risk of cognitive impairments including Alzheimer's disease dementia. Legally authorized representatives (LARs) can provide informed consent when a participant is no longer able to, but little is known about barriers to incorporating them in research., Objective: Explore reasons for not asking and documenting participant decisions to appoint LARs among researchers conducting clinical intervention trials studying older adults or individuals with cognitive impairments., Methods: Mixed method design consisting of a survey ( N = 1,284) and qualitative interviews ( N = 40) regarding barriers to incorporating LARs. Participants were principal investigators and clinical research coordinators., Results: 37% ( N = 469) had not asked and documented participant decisions about appointing LARs in the prior year. They had significantly lower confidence in resources available to incorporate LARs and lower positive attitudes compared to their counterparts who had done so. The majority (83%) had no trials studying individuals with cognitive impairments and reported LARs were not applicable. A minority (17%) had at least one trial studying individuals with cognitive impairments and reported being unaware of LARs. Qualitative findings indicate discomfort broaching a sensitive topic especially with individuals who are not yet impaired., Conclusion: Resources and education to increase awareness and knowledge of LARs are needed. Researchers studying older adults should, at minimum, have the knowledge and resources to incorporate LARs when necessary. Stigma and discomfort discussing LARs will need to be overcome, as early proactive discussions before a participant loses decisional capacity could enhance participant autonomy and facilitate recruitment and retention of older adults to research., Competing Interests: The authors have no conflict of interest to report., (© 2023 – The authors. Published by IOS Press.)
- Published
- 2023
- Full Text
- View/download PDF
16. Advice to Clinicians on Communication from Adolescents and Young Adults with Cancer and Parents of Children with Cancer.
- Author
-
Srinivas M, Kaye EC, Blazin LJ, Baker JN, Mack JW, DuBois JM, and Sisk BA
- Abstract
Effective communication is integral to patient and family-centered care in pediatric and adolescent and young adult (AYA) oncology and improving healthcare delivery and outcomes. There is limited knowledge about whether AYAs and parents have similar communication preferences and needs. By eliciting and comparing communication advice from AYAs and parents, we can identify salient guidance for how clinicians can better communicate. We performed secondary analysis of semi-structured interviews from 2 qualitative communication studies. In one study, 80 parents of children with cancer during treatment, survivorship, or bereavement were interviewed. In the second study, AYAs with cancer during treatment or survivorship were interviewed. We asked AYAs and parents to provide communication advice for oncology clinicians. Using thematic analysis, we identified categories of advice related to three overarching themes: interpersonal relationships, informational preferences, and delivery of treatment, resources, and medical care. AYAs and parents provided similar advice about the need for compassion, strong connections, hopefulness, commitment, and transparent honesty However, AYAs placed additional emphasis on clinicians maintaining a calm demeanor.
- Published
- 2022
- Full Text
- View/download PDF
17. A randomized implementation trial to increase adoption of evidence-informed consent practices.
- Author
-
Solomon ED, Mozersky J, Goodman M, Parsons MV, Baldwin KA, Friedrich AB, Harris JK, and DuBois JM
- Abstract
Introduction: Several evidence-informed consent practices (ECPs) have been shown to improve informed consent in clinical trials but are not routinely used. These include optimizing consent formatting, using plain language, using validated instruments to assess understanding, and involving legally authorized representatives when appropriate. We hypothesized that participants receiving an implementation science toolkit and a social media push would have increased adoption of ECPs and other outcomes., Methods: We conducted a 1-year trial with clinical research professionals in the USA ( n = 1284) who have trials open to older adults or focus on Alzheimer's disease. We randomized participants to receive information on ECPs via receiving a toolkit with a social media push (intervention) or receiving an online learning module (active control). Participants completed a baseline survey and a follow-up survey after 1 year. A subset of participants was interviewed ( n = 43)., Results: Participants who engaged more with the toolkit were more likely to have tried to implement an ECP during the trial than participants less engaged with the toolkit or the active control group. However, there were no significant differences in the adoption of ECPs, intention to adopt, or positive attitudes. Participants reported the toolkit and social media push were satisfactory, and participating increased their awareness of ECPs. However, they reported lacking the time needed to engage with the toolkit more fully., Conclusions: Using an implementation science approach to increase the use of ECPs was only modestly successful. Data suggest that having institutional review boards recommend or require ECPs may be an effective way to increase their use., (© The Author(s) 2022.)
- Published
- 2022
- Full Text
- View/download PDF
18. Author Correction: [ 11 C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer's disease.
- Author
-
Pascoal TA, Chamoun M, Lax E, Wey HY, Shin M, Ng KP, Kang MS, Mathotaarachchi S, Benedet AL, Therriault J, Lussier FZ, Schroeder FA, DuBois JM, Hightower BG, Gilbert TM, Zürcher NR, Wang C, Hopewell R, Chakravarty M, Savard M, Thomas E, Mohaddes S, Farzin S, Salaciak A, Tullo S, Cuello AC, Soucy JP, Massarweh G, Hwang H, Kobayashi E, Hyman BT, Dickerson BC, Guiot MC, Szyf M, Gauthier S, Hooker JM, and Rosa-Neto P
- Published
- 2022
- Full Text
- View/download PDF
19. [ 11 C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer's disease.
- Author
-
Pascoal TA, Chamoun M, Lax E, Wey HY, Shin M, Ng KP, Kang MS, Mathotaarachchi S, Benedet AL, Therriault J, Lussier FZ, Schroeder FA, DuBois JM, Hightower BG, Gilbert TM, Zürcher NR, Wang C, Hopewell R, Chakravarty M, Savard M, Thomas E, Mohaddes S, Farzin S, Salaciak A, Tullo S, Cuello AC, Soucy JP, Massarweh G, Hwang H, Kobayashi E, Hyman BT, Dickerson BC, Guiot MC, Szyf M, Gauthier S, Hooker JM, and Rosa-Neto P
- Subjects
- Adamantane analogs & derivatives, Amyloid beta-Peptides metabolism, Animals, Brain metabolism, Histone Deacetylases genetics, Histone Deacetylases metabolism, Humans, Hydroxamic Acids, Positron-Emission Tomography methods, Rats, tau Proteins metabolism, Alzheimer Disease diagnostic imaging, Alzheimer Disease genetics, Alzheimer Disease metabolism, Cognitive Dysfunction diagnostic imaging, Cognitive Dysfunction genetics, Cognitive Dysfunction metabolism, Histone Deacetylase 1 metabolism
- Abstract
Alzheimer's disease (AD) is characterized by the brain accumulation of amyloid-β and tau proteins. A growing body of literature suggests that epigenetic dysregulations play a role in the interplay of hallmark proteinopathies with neurodegeneration and cognitive impairment. Here, we aim to characterize an epigenetic dysregulation associated with the brain deposition of amyloid-β and tau proteins. Using positron emission tomography (PET) tracers selective for amyloid-β, tau, and class I histone deacetylase (HDAC I isoforms 1-3), we find that HDAC I levels are reduced in patients with AD. HDAC I PET reduction is associated with elevated amyloid-β PET and tau PET concentrations. Notably, HDAC I reduction mediates the deleterious effects of amyloid-β and tau on brain atrophy and cognitive impairment. HDAC I PET reduction is associated with 2-year longitudinal neurodegeneration and cognitive decline. We also find HDAC I reduction in the postmortem brain tissue of patients with AD and in a transgenic rat model expressing human amyloid-β plus tau pathology in the same brain regions identified in vivo using PET. These observations highlight HDAC I reduction as an element associated with AD pathophysiology., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
20. Responding to Sexual Abuse in Health Care: Development of a Guide for Patients.
- Author
-
McIntosh T, Walsh H, Parsons M, Solomon ED, Mozersky J, and DuBois JM
- Abstract
This report details the development of a stakeholder- and evidence-informed online resource guide for patients that provides information to raise awareness about sexual abuse in health care, the value of chaperones, and options for responding to sexual abuse. The guide was developed to reflect lessons learned from 10 years of researching physician wrongdoing (ie, sexual violations, improper prescribing, and unnecessary invasive procedures), a 5-year National Institutes of Health-funded mixed-methods study of 280 cases of egregious wrongdoing in medicine, and an expert working group. Focus groups were conducted with 22 patients from diverse backgrounds to obtain feedback on the acceptability of the guide. Thematic analysis of the focus groups yielded 6 key themes: 1) empowering patients, 2) recognizing and responding to sexual abuse, 3) educating patients about reporting options, 4) educating patients on availability of chaperones, 5) balancing trust and mistrust, and 6) using simple language. Qualitative data from the focus groups (ie, audio files and detailed notes taken by the research team) suggested that the guide effectively informed and empowered patients to recognize and effectively respond to sexual misconduct in health care. The guide is publicly available and has been disseminated nationally to patient health advocates and public health agencies., Competing Interests: Conflicts of Interest None., (© 2022 Aurora Health Care, Inc.)
- Published
- 2022
- Full Text
- View/download PDF
21. Ethical, regulatory, and practical barriers to COVID-19 research: A stakeholder-informed inventory of concerns.
- Author
-
Sisk BA, Baldwin K, Parsons M, and DuBois JM
- Subjects
- Ethics Committees, Research, Humans, Pandemics, Research Personnel, SARS-CoV-2, COVID-19 epidemiology
- Abstract
Introduction: SARS-CoV-2 (COVID-19) has caused death and economic injury around the globe. The urgent need for COVID-19 research created new ethical, regulatory, and practical challenges. The next public health emergency could be worse than COVID-19. We must learn about these challenges from the experiences of researchers and Research Ethics Committee professionals responsible for these COVID-19 studies to prepare for the next emergency., Materials and Methods: We conducted an online survey to identify the ethical, oversight, and regulatory challenges of conducting COVID-19 research during the early pandemic, and proposed solutions for overcoming these barriers. Using criterion-based, convenience sampling, we invited researchers who proposed or conducted COVID-19 research to complete an anonymous, online survey about their experiences. We administered a separate but related survey to Institutional Review Board (IRB) professionals who reviewed COVID-19 research studies. The surveys included open-ended and demographic items. We performed inductive content analysis on responses to open-ended survey questions., Results: IRB professionals (n = 143) and researchers (n = 211) described 19 types of barriers to COVID-19 research, related to 5 overarching categories: policy and regulatory, biases and misperceptions, institutional and inter-institutional conflicts, risks of harm, and pressure of the pandemic. Researchers and IRB professionals described 8 categories of adaptations and solutions to these challenges: enacting technological solutions; developing protocol-based solutions; disposition and team management; establishing and communicating appropriate standards; national guidance and leadership; maintaining high standards; prioritizing studies before IRB review; and identifying and incorporating experts., Discussion and Conclusions: This inventory of challenges represents ongoing barriers to studying the current pandemic, and they represent a risk to research during future public health emergencies. Delays in studies of a pandemic during a pandemic threatens the health and safety of the public. We urge the development of a national working group to address these issues before the next public health emergency arises., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2022
- Full Text
- View/download PDF
22. Corrigendum to: Enabling qualitative research data sharing using a natural language processing pipeline for deidentification: moving beyond HIPAA Safe Harbor identifiers.
- Author
-
Gupta A, Lai A, Mozersky J, Ma X, Walsh H, and DuBois JM
- Abstract
[This corrects the article DOI: 10.1093/jamiaopen/ooab069.]., (© The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.)
- Published
- 2022
- Full Text
- View/download PDF
23. A Content Analysis of 100 Qualitative Health Research Articles to Examine Researcher-Participant Relationships and Implications for Data Sharing.
- Author
-
Mozersky J, Friedrich AB, and DuBois JM
- Abstract
We conducted a qualitative content analysis of health science literature ( N = 100) involving qualitative interviews or focus groups. Given recent data sharing mandates, our goal was to characterize the nature of relationships between the researchers and participants to inform ethical deliberations regarding qualitative data sharing and secondary analyses. Specifically, some researchers worry that data sharing might harm relationships, while others claim that data cannot be analyzed absent meaningful relationships with participants. We found little evidence of relationship building with participants. The majority of studies involve single encounters (95%), lasting less than 60 min (59%), with less than half of authors involved in primary data collection. Our findings suggest that relationships with participants might not pose a barrier to sharing some qualitative data collected in the health sciences and speak to the feasibility in principle of secondary analyses of these data., Competing Interests: Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2022
- Full Text
- View/download PDF
24. Barriers and facilitators to qualitative data sharing in the United States: A survey of qualitative researchers.
- Author
-
Mozersky J, McIntosh T, Walsh HA, Parsons MV, Goodman M, and DuBois JM
- Subjects
- Adult, Biomedical Research, Data Accuracy, Data Collection, Female, Humans, Male, Middle Aged, National Institutes of Health (U.S.), Public Health, Surveys and Questionnaires, Trust, United States, Access to Information, Information Dissemination, Qualitative Research, Research Personnel
- Abstract
Qualitative health data are rarely shared in the United States (U.S.). This is unfortunate because gathering qualitative data is labor and time-intensive, and data sharing enables secondary research, training, and transparency. A new U.S. federal policy mandates data sharing by 2023, and is agnostic to data type. We surveyed U.S. qualitative researchers (N = 425) on the barriers and facilitators of sharing qualitative health or sensitive research data. Most researchers (96%) have never shared qualitative data in a repository. Primary concerns were lack of participant permission to share data, data sensitivity, and breaching trust. Researcher willingness to share would increase if participants agreed and if sharing increased the societal impact of their research. Key resources to increase willingness to share were funding, guidance, and de-identification assistance. Public health and biomedical researchers were most willing to share. Qualitative researchers need to prepare for this new reality as sharing qualitative data requires unique considerations., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2021
- Full Text
- View/download PDF
25. Enabling qualitative research data sharing using a natural language processing pipeline for deidentification: moving beyond HIPAA Safe Harbor identifiers.
- Author
-
Gupta A, Lai A, Mozersky J, Ma X, Walsh H, and DuBois JM
- Abstract
Objective: Sharing health research data is essential for accelerating the translation of research into actionable knowledge that can impact health care services and outcomes. Qualitative health research data are rarely shared due to the challenge of deidentifying text and the potential risks of participant reidentification. Here, we establish and evaluate a framework for deidentifying qualitative research data using automated computational techniques including removal of identifiers that are not considered HIPAA Safe Harbor (HSH) identifiers but are likely to be found in unstructured qualitative data., Materials and Methods: We developed and validated a pipeline for deidentifying qualitative research data using automated computational techniques. An in-depth analysis and qualitative review of different types of qualitative health research data were conducted to inform and evaluate the development of a natural language processing (NLP) pipeline using named-entity recognition, pattern matching, dictionary, and regular expression methods to deidentify qualitative texts., Results: We collected 2 datasets with 1.2 million words derived from over 400 qualitative research data documents. We created a gold-standard dataset with 280K words (70 files) to evaluate our deidentification pipeline. The majority of identifiers in qualitative data are non-HSH and not captured by existing systems. Our NLP deidentification pipeline had a consistent F1-score of ∼0.90 for both datasets., Conclusion: The results of this study demonstrate that NLP methods can be used to identify both HSH identifiers and non-HSH identifiers. Automated tools to assist researchers with the deidentification of qualitative data will be increasingly important given the new National Institutes of Health (NIH) data-sharing mandate., (© The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.)
- Published
- 2021
- Full Text
- View/download PDF
26. Exploring perceptions of healthcare technologies enabled by artificial intelligence: an online, scenario-based survey.
- Author
-
Antes AL, Burrous S, Sisk BA, Schuelke MJ, Keune JD, and DuBois JM
- Subjects
- Adult, Biomedical Technology, Humans, Perception, Surveys and Questionnaires, Artificial Intelligence, Delivery of Health Care
- Abstract
Background: Healthcare is expected to increasingly integrate technologies enabled by artificial intelligence (AI) into patient care. Understanding perceptions of these tools is essential to successful development and adoption. This exploratory study gauged participants' level of openness, concern, and perceived benefit associated with AI-driven healthcare technologies. We also explored socio-demographic, health-related, and psychosocial correlates of these perceptions., Methods: We developed a measure depicting six AI-driven technologies that either diagnose, predict, or suggest treatment. We administered the measure via an online survey to adults (N = 936) in the United States using MTurk, a crowdsourcing platform. Participants indicated their level of openness to using the AI technology in the healthcare scenario. Items reflecting potential concerns and benefits associated with each technology accompanied the scenarios. Participants rated the extent that the statements of concerns and benefits influenced their perception of favorability toward the technology. Participants completed measures of socio-demographics, health variables, and psychosocial variables such as trust in the healthcare system and trust in technology. Exploratory and confirmatory factor analyses of the concern and benefit items identified two factors representing overall level of concern and perceived benefit. Descriptive analyses examined levels of openness, concern, and perceived benefit. Correlational analyses explored associations of socio-demographic, health, and psychosocial variables with openness, concern, and benefit scores while multivariable regression models examined these relationships concurrently., Results: Participants were moderately open to AI-driven healthcare technologies (M = 3.1/5.0 ± 0.9), but there was variation depending on the type of application, and the statements of concerns and benefits swayed views. Trust in the healthcare system and trust in technology were the strongest, most consistent correlates of openness, concern, and perceived benefit. Most other socio-demographic, health-related, and psychosocial variables were less strongly, or not, associated, but multivariable models indicated some personality characteristics (e.g., conscientiousness and agreeableness) and socio-demographics (e.g., full-time employment, age, sex, and race) were modestly related to perceptions., Conclusions: Participants' openness appears tenuous, suggesting early promotion strategies and experiences with novel AI technologies may strongly influence views, especially if implementation of AI technologies increases or undermines trust. The exploratory nature of these findings warrants additional research., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
27. In vivo hippocampal cornu ammonis 1-3 glutamatergic abnormalities are associated with temporal lobe epilepsy surgery outcomes.
- Author
-
Lam J, DuBois JM, Rowley J, Rousset OG, González-Otárula KA, Soucy JP, Massarweh G, Hall JA, Guiot MC, Zimmermann M, Minuzzi L, Rosa-Neto P, and Kobayashi E
- Subjects
- Adolescent, Adult, Aged, CA1 Region, Hippocampal metabolism, CA3 Region, Hippocampal, Epilepsy, Temporal Lobe diagnostic imaging, Female, Fluorodeoxyglucose F18, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Oximes, Positron-Emission Tomography, Pyridines, Radiopharmaceuticals, Receptors, Kainic Acid metabolism, Treatment Outcome, Young Adult, Epilepsy, Temporal Lobe genetics, Epilepsy, Temporal Lobe surgery, Glutamic Acid genetics, Hippocampus metabolism, Neurosurgical Procedures, Receptors, Kainic Acid genetics
- Abstract
Objective: Previous positron emission tomography (PET) studies using [
11 C]ABP688 show reduced metabotropic glutamate receptor type 5 (mGluR5) allosteric binding site availability in the epileptogenic hippocampus of mesial temporal lobe epilepsy (MTLE) patients. However, the link between mGluR5 abnormalities and postsurgical outcomes remains unclear. Here, we test whether reduced PET [11 C]ABP688 binding in cornu ammonis (CA) sectors more vulnerable to glutamatergic excitotoxicity relates to surgical outcomes., Methods: We obtained magnetic resonance imaging (MRI) and [11 C]ABP688-PET from 31 unilateral MTLE patients and 30 healthy controls. MRI hippocampal subfields were segmented using FreeSurfer. To respect the lower PET special resolution, MRI-derived anatomical subfields were combined into CA1-3, CA4/dentate gyrus, and Subiculum. Partial volume corrected [11 C]ABP688 nondisplaceable binding potential (BPND ) values were averaged across each subfield, and Z-scores were calculated. Subfield [11 C]ABP688-BPND was compared between seizure-free and non-seizure-free patients. In addition, we also assessed subfield volumes and [18 F]fluorodeoxyglucose (FDG) uptake in each clinical group., Results: MTLE [11 C]ABP688-BPND was reduced in ipsilateral (epileptogenic) CA1-3 and CA4/dentate-gyrus (p < .001, 95% confidence interval [CI] = .29-.51) compared to controls, with no difference in Subiculum. [11 C]ABP688-BPND and subfield volumes were compared between seizure-free (Engel IA, n = 13) and non-seizure-free patients (Engel IC-III, n = 10). In ipsilateral CA1-3 only, [11 C]ABP688-BPND was lower in seizure-free patients than in non-seizure-free patients (p = .012, 95% CI = 1.46-11.0) independently of volume. A subset analysis of 12 patients with [11 C]ABP688-PET+[18 F]FDG-PET showed no between-group significant difference in [18 F]FDG uptake, whereas CA1-3 [11 C]ABP688-BPND remained significantly lower in the seven of 12 seizure-free patients (p = .03, 95% CI = -3.13 to -.21)., Significance: Reduced mGluR5 allosteric site availability in hippocampal CA1-3, measured in vivo by [11 C]ABP688-PET, is associated with postsurgery seizure freedom independent of atrophy or hypometabolism. Information derived from hippocampal CA1-3 [11 C]ABP688-PET is a promising imaging biomarker potentially impactful in surgical decisions for MRI-negative/PET-negative MTLE patients., (© 2021 International League Against Epilepsy.)- Published
- 2021
- Full Text
- View/download PDF
28. Collective Apathy and Racial Health Disparities in the USA: the Need for Empathy-Building and Examples of Positive Change.
- Author
-
DuBois JM
- Subjects
- Health Status Disparities, Humans, Racial Groups, United States epidemiology, White People, Apathy, Empathy
- Published
- 2021
- Full Text
- View/download PDF
29. Perceived barriers to assessing understanding and appreciation of informed consent in clinical trials: A mixed-method study.
- Author
-
Solomon ED, Mozersky J, Baldwin K, Wroblewski MP, Parsons MV, Goodman M, and DuBois JM
- Abstract
Introduction: Participants and research professionals often overestimate how well participants understand and appreciate consent information for clinical trials, and experts often vary in their determinations of participant's capacity to consent to research. Past research has developed and validated instruments designed to assess participant understanding and appreciation, but the frequency with which they are utilized is unknown., Methods: We administered a survey to clinical researchers working with older adults or those at risk of cognitive impairment ( N = 1284), supplemented by qualitative interviews ( N = 60)., Results: We found that using a validated assessment of consent is relatively uncommon, being used by only 44% of researchers who had an opportunity. Factors that predicted adoption of validated assessments included not seeing the study sponsor as a barrier, positive attitudes toward assessments, and being confident that they had the resources needed to implement an assessment. The perceived barriers to adopting validated assessments of consent included lack of awareness, lack of knowledge, being unsure of how to administer such an assessment, and the burden associated with implementing this practice., Conclusions: Increasing the use of validated assessments of consent will require educating researchers on the practice and emphasizing very practical assessments, and may require Institutional Review Boards (IRBs) or study sponsors to champion the use of assessments., Competing Interests: The authors have no conflicts of interest to declare., (© The Association for Clinical and Translational Science 2021.)
- Published
- 2021
- Full Text
- View/download PDF
30. Attitudes toward genomics and precision medicine.
- Author
-
DuBois JM, Mozersky J, Antes A, English T, Parsons MV, and Baldwin K
- Abstract
Purpose: This paper reports on a novel measure, attitudes toward genomics and precision medicine (AGPM), which evaluates attitudes toward activities such as genetic testing, collecting information on lifestyle, and genome editing - activities necessary to achieve the goals of precision medicine., Discussion: The AGPM will be useful for researchers who want to explore attitudes toward genomics and precision medicine. The association of concerns about precision medicine activities with demographic variables such as religion and politics, as well as higher levels of education, suggests that further education on genomic and precision activities alone is unlikely to shift AGPM scores significantly., Methods: We wrote items to represent psychological and health benefits of precision medicine activities, and concerns about privacy, social justice, harm to embryos, and interfering with nature. We validated the measure through factor analysis of its structure, and testing associations with trust in the health information system and demographic variables such as age, sex, education, and religion., Results: The AGPM had excellent alpha reliability (.92) and demonstrated good convergent validity with existing measures. Variables most strongly associated with higher levels of concern with precision medicine activities included: regular religious practice, republican political leanings, and higher levels of education., Competing Interests: The authors have no conflicts of interest to declare., (© The Association for Clinical and Translational Science 2021.)
- Published
- 2021
- Full Text
- View/download PDF
31. Large-scale mGluR5 network abnormalities linked to epilepsy duration in focal cortical dysplasia.
- Author
-
DuBois JM, Mathotaarachchi S, Rousset OG, Sziklas V, Sepulcre J, Guiot MC, Hall JA, Massarweh G, Soucy JP, Rosa-Neto P, and Kobayashi E
- Subjects
- Brain diagnostic imaging, Carbon Radioisotopes, Humans, Positron-Emission Tomography, Epilepsy diagnostic imaging, Malformations of Cortical Development diagnostic imaging
- Abstract
To determine the extent of metabotropic glutamate receptor type 5 (mGluR5) network abnormalities associated with focal cortical dysplasia (FCD), we performed graph theoretical analysis of [
11 C]ABP688 PET binding potentials (BPND ), which allows for quantification of mGluR5 availability. Undirected graphs were constructed for the entire cortex in 17 FCD patients and 33 healthy controls using inter-regional similarity of [11 C]ABP688 BPND . We assessed group differences in network integration between healthy controls and the ipsilateral and contralateral hemispheres of FCD patients. Compared to healthy controls, FCD patients showed reduced network efficiency and reduced small-world connectivity. The mGluR5 network of FCD patients was also less resilient to targeted removal of high centrality nodes, suggesting a less integrated network organization. In highly efficient hub nodes of FCD patients, we observed a significant negative correlation between local efficiency and duration of epilepsy only in the contralateral hemisphere, suggesting that some nodes may be more vulnerable to persistent epileptic activity. Our study provides the first in vivo evidence for a widespread reduction in cortical mGluR5 network integration in FCD patients. In addition, we find that ongoing epileptic activity may alter chemoarchitectural brain organization resulting in reduced efficiency in distant regions that are essential for network integration., (Copyright © 2020. Published by Elsevier Inc.)- Published
- 2021
- Full Text
- View/download PDF
32. Parental Attitudes toward Artificial Intelligence-Driven Precision Medicine Technologies in Pediatric Healthcare.
- Author
-
Sisk BA, Antes AL, Burrous S, and DuBois JM
- Abstract
Precision medicine relies upon artificial intelligence (AI)-driven technologies that raise ethical and practical concerns. In this study, we developed and validated a measure of parental openness and concerns with AI-driven technologies in their child's healthcare. In this cross-sectional survey, we enrolled parents of children <18 years in 2 rounds for exploratory ( n = 418) and confirmatory ( n = 386) factor analysis. We developed a 12-item measure of parental openness to AI-driven technologies, and a 33-item measure identifying concerns that parents found important when considering these technologies. We also evaluated associations between openness and attitudes, beliefs, personality traits, and demographics. Parents ( N = 804) reported mean openness to AI-driven technologies of M = 3.4/5, SD = 0.9. We identified seven concerns that parents considered important when evaluating these technologies: quality/accuracy, privacy, shared decision making, convenience, cost, human element of care, and social justice. In multivariable linear regression, parental openness was positively associated with quality (beta = 0.23), convenience (beta = 0.16), and cost (beta = 0.11), as well as faith in technology (beta = 0.23) and trust in health information systems (beta = 0.12). Parental openness was negatively associated with the perceived importance of shared decision making (beta = -0.16) and being female (beta = -0.12). Developers might support parental openness by addressing these concerns during the development and implementation of novel AI-driven technologies.
- Published
- 2020
- Full Text
- View/download PDF
33. The National Institute of Allergy and Infectious Diseases Decision to Stop the Adaptive COVID-19 Trial: On Solid Ethical and Scientific Grounds.
- Author
-
Mozersky J, Mann DL, and DuBois JM
- Published
- 2020
- Full Text
- View/download PDF
34. Assessing clinical research coordinator knowledge of good clinical practice: An evaluation of the state of the art and a test validation study.
- Author
-
DuBois JM, Mozersky JT, Antes AL, Baldwin K, and Jenkerson M
- Abstract
This paper describes the development and validation of a new 32-item test of knowledge of good clinical practice (GCP) administered to 625 clinical research coordinators. GCP training is mandated by study sponsors including the US National Institutes of Health. The effectiveness of training is rarely assessed, and the lack of validated tests is an obstacle to assessment. The GCP knowledge test was developed following evaluation of two existing widely used GCP tests to ensure it accurately reflects the content of current training. The final GCP knowledge test demonstrated good reliability ( α = 0.69). It is a valid and reliable instrument for measuring knowledge of GCP. The test will be useful in assessing the effectiveness of GCP training programs as well as individuals' mastery of GCP content., (© The Association for Clinical and Translational Science 2020.)
- Published
- 2020
- Full Text
- View/download PDF
35. Professional decision-making in medicine: Development of a new measure and preliminary evidence of validity.
- Author
-
Antes AL, Dineen KK, Bakanas E, Zahrli T, Keune JD, Schuelke MJ, and DuBois JM
- Subjects
- Adult, Educational Measurement, Female, Humans, Male, Morals, Reproducibility of Results, Surveys and Questionnaires, Clinical Competence, Decision Making ethics, Education, Medical, Undergraduate ethics, Professionalism trends, Students, Medical psychology
- Abstract
Introduction: This study developed a new Professional Decision-Making in Medicine Measure that assesses the use of effective decision-making strategies: seek help, manage emotions, recognize consequences and rules, and test assumptions and motives. The aim was to develop a content valid measure and obtain initial evidence for construct validity so that the measure could be used in future research or educational assessment., Methods: Clinical scenario-based items were developed based on a review of the literature and interviews with physicians. For each item, respondents are tasked with selecting two responses (out of six plausible options) that they would choose in that situation. Three of the six options reflect a decision-making strategy; these responses are scored as correct. Data were collected from a sample of 318 fourth-year medical students in the United States. They completed a 16-item version of the measure (Form A) and measures of social desirability, moral disengagement, and professionalism attitudes. Professionalism ratings from clerkships were also obtained. A sub-group (n = 63) completed a second 16-item measure (Form B) to pilot test the instrument, as two test forms are useful for pre-posttest designs., Results: Scores on the new measure indicated that, on average, participants answered 75% of items correctly. Evidence for construct validity included the lack of correlation between scores on the measure and socially desirable responding, negative correlation with moral disengagement, and modest to low correlations with professionalism attitudes. A positive correlation was observed with a clerkship rating focused on professionalism in peer interactions., Conclusions: These findings demonstrate modest proficiency in the use of decision-making strategies among fourth-year medical students. Additional research using the Professional Decision-Making Measure should explore scores among physicians in various career stages, and the causes and correlates of scores. Educators could utilize the measure to assess courses that teach decision-making strategies., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2020
- Full Text
- View/download PDF
36. How are US institutions implementing the new key information requirement?
- Author
-
Mozersky J, Wroblewski MP, Solomon ED, and DuBois JM
- Abstract
Recent revisions to the Federal Policy for the Protections of Human Subjects require that informed consent documents begin with a "concise and focused presentation" of the key information a participant requires. Key information "must be organized and presented in a way that facilitates comprehension." The regulations do not specify what information be included, nor how it must be presented to facilitate comprehension. It is unknown how institutions and Institutional Review Boards (IRBs) are interpreting the current regulations. We conducted a review of randomly sampled available key information templates at 46 US medical institutions to determine how they are implementing the new regulations., Competing Interests: The authors have no conflicts of interest to declare., (© The Association for Clinical and Translational Science 2020.)
- Published
- 2020
- Full Text
- View/download PDF
37. Are we ready to share qualitative research data? Knowledge and preparedness among qualitative researchers, IRB Members, and data repository curators.
- Author
-
Mozersky J, Walsh H, Parsons M, McIntosh T, Baldwin K, and DuBois JM
- Abstract
Data sharing maximizes the value of data, which is time and resource intensive to collect. Major funding bodies in the United States (US), like the National Institutes of Health (NIH), require data sharing and researchers frequently share de-identified quantitative data. In contrast, qualitative data are rarely shared in the US but the increasing trend towards data sharing and open science suggest this may be required in future. Qualitative methods are often used to explore sensitive health topics raising unique ethical challenges regarding protecting confidentiality while maintaining enough contextual detail for secondary analyses. Here, we report findings from semi-structured in-depth interviews with 30 data repository curators, 30 qualitative researchers, and 30 IRB staff members to explore their experience and knowledge of QDS. Our findings indicate that all stakeholder groups lack preparedness for QDS. Researchers are the least knowledgeable and are often unfamiliar with the concept of sharing qualitative data in a repository. Curators are highly supportive of QDS, but not all have experienced curating qualitative data sets and indicated they would like guidance and standards specific to QDS. IRB members lack familiarity with QDS although they support it as long as proper legal and regulatory procedures are followed. IRB members and data curators are not prepared to advise researchers on legal and regulatory matters, potentially leaving researchers who have the least knowledge with no guidance. Ethical and productive QDS will require overcoming barriers, creating standards, and changing long held practices among all stakeholder groups.
- Published
- 2020
- Full Text
- View/download PDF
38. The lab management practices of "Research Exemplars" that foster research rigor and regulatory compliance: A qualitative study of successful principal investigators.
- Author
-
Antes AL, Kuykendall A, and DuBois JM
- Subjects
- Adult, Biomedical Research organization & administration, Female, Financing, Government, Humans, Male, Middle Aged, National Institutes of Health (U.S.), Professionalism, Qualitative Research, Reproducibility of Results, Research Support as Topic, United States, Biomedical Research economics, Biomedical Research trends, Leadership, Research Personnel
- Abstract
Introduction: Conducting rigorous scientific inquiry within the bounds of research regulation and acceptable practice requires a principal investigator to lead and manage research processes and personnel. This study explores the practices used by investigators nominated as exemplars of research excellence and integrity to produce rigorous, reproducible research and comply with research regulations., Methods: Using a qualitative research design, we interviewed 52 principal investigators working in the United States at top research universities and the National Institutes of Health Intramural Research Program. We solicited nominations of researchers meeting two criteria: (1) they are federally-funded researchers doing high-quality, high-impact research, and (2) have reputations for professionalism and integrity. Each investigator received an initial nomination addressing both criteria and at least one additional endorsement corroborating criteria 2. A panel of researchers and our research team reviewed the nominations to select finalists who were invited to participate. The cohort of "Research Exemplars" includes highly accomplished researchers in diverse scientific disciplines. The semi-structured interview questions asked them to describe the routine practices they employ to foster rigor and regulatory compliance. We used inductive thematic analysis to identify common practices., Results: The exemplars identified a core set of 8 practices and provided strategies for employing them. The practices included holding regular team meetings, encouraging shared ownership, providing supervision, ensuring adequate training, fostering positive attitudes about compliance, scrutinizing data and findings, and following standard operating procedures. Above all, the use of these practices aim to create a psychologically safe work environment in which lab members openly collaborate to scrutinize their work and share in accountability for rigorous, compliant research., Conclusions: Researchers typically receive limited systematic training in how to lead and manage their research teams. Training and education for principal investigators should include essential leadership and management practices and strategies that support doing high-quality research with integrity., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
39. Preventing Egregious Ethical Violations in Medical Practice: Evidence-Informed Recommendations from a Multidisciplinary Working Group.
- Author
-
DuBois JM, Anderson EE, Chibnall JT, Diakov L, Doukas DJ, Holmboe ES, Koenig HM, Krause JH, McMillan G, Mendelsohn M, Mozersky J, Norcross WA, and Whelan AJ
- Abstract
This article reports the consensus recommendations of a working group that was convened at the end of a 4-year research project funded by the National Institutes of Health that examined 280 cases of egregious ethical violations in medical practice. The group reviewed data from the parent project, as well as other research on sexual abuse of patients, criminal prescribing of controlled substances, and unnecessary invasive procedures that were prosecuted as fraud. The working group embraced the goals of making such violations significantly less frequent and, when they do occur, identifying them sooner and taking necessary steps to ensure they are not repeated. Following review of data and previously published recommendations, the working group developed 10 recommendations that provide a starting point to meet these goals. Recommendations address leadership, oversight, tracking, disciplinary actions, education of patients, partnerships with law enforcement, further research and related matters. The working group recognized the need for further refinement of the recommendations to ensure feasibility and appropriate balance between protection of patients and fairness to physicians. While full implementation of appropriate measures will require time and study, we believe it is urgent to take visible actions to acknowledge and address the problem at hand.
- Published
- 2018
- Full Text
- View/download PDF
40. Cultivating the Human Dimension in Research.
- Author
-
Antes AL and DuBois JM
- Subjects
- Humans, Leadership, Research Personnel, Research
- Abstract
According to "Research Exemplars," research requires attending to matters of heart as much as mind. The human dimension in research-relationships, passion, resilience, and leadership-was the common thread in their advice for a successful career. We discuss strategies to cultivate intra- and inter-personal skills fostering these aspects of research., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
41. Exploring unnecessary invasive procedures in the United States: a retrospective mixed-methods analysis of cases from 2008-2016.
- Author
-
DuBois JM, Chibnall JT, Anderson EE, Walsh HA, Eggers M, Baldwin K, and Dineen KK
- Abstract
Background: Unnecessary invasive procedures risk harming patients physically, emotionally, and financially. Very little is known about the factors that provide the motive, means, and opportunity (MMO) for unnecessary procedures., Methods: This project used a mixed-methods design that involved five key steps: (1) systematically searching the literature to identify cases of unnecessary procedures reported from 2008 to 2016; (2) identifying all medical board, court, and news records on relevant cases; (3) coding all relevant records using a structured codebook of case characteristics; (4) analyzing each case using a MMO framework to develop a causal theory of the case; and (5) identifying typologies of cases through a two-step cluster analysis using variables hypothesized to be causally related to unnecessary procedures., Results: Seventy-nine cases met inclusion criteria. The mean number of documents or sources examined for each case was 36.4. Unnecessary procedures were performed for at least five years in most cases (53.2%); 56.3% of the cases involved 30 or more patients, and 37.5% involved 100 or more patients. In nearly all cases the physician was male (96.2%) and working in private practice (92.4%); 57.0% of the physicians had an accomplice, 48.1% were 50 years of age or older, and 40.5% trained outside the U.S. The most common motives were financial gain (92.4%) and suspected antisocial personality (48.1%), followed by poor problem-solving or clinical skills (11.4%) and ambition (3.8%). The most common environmental factors that provided opportunity for unnecessary procedures included a lack of oversight (40.5%) or oversight failures (39.2%), a corrupt moral climate (26.6%), vulnerable patients (20.3%), and financial conflicts of interest (13.9%)., Conclusions: Unnecessary procedures usually appear motivated by financial gain and occur in settings that have oversight problems. Preventive efforts should focus on early detection by peers and institutions, and decisive action by medical boards and federal prosecutors., Competing Interests: Not applicable.Not applicable.James DuBois serves as a paid medical ethics consultant to Centene Corp. No funding for this project was provided by Centene Corp.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- Published
- 2017
- Full Text
- View/download PDF
42. Knowing Your Limits: A Qualitative Study of Physician and Nurse Practitioner Perspectives on NP Independence in Primary Care.
- Author
-
Kraus E and DuBois JM
- Subjects
- Adult, Aged, Cooperative Behavior, Female, Humans, Male, Middle Aged, Nurse Practitioners legislation & jurisprudence, Patient Protection and Affordable Care Act, Practice Patterns, Nurses', Primary Health Care organization & administration, Qualitative Research, Quality of Health Care, Young Adult, Attitude of Health Personnel, Nurse Practitioners psychology, Nurse's Role, Physicians, Primary Care psychology, Professional Autonomy
- Abstract
Background: The shortage of primary care providers and the provisions of the Affordable Care Act (ACA) have spurred discussion about expanding the number, scope of practice (SOP), and independence of primary care nurse practitioners (NPs). Such discussions in the media and among professional organizations may insinuate that changes to the laws governing NP practice will engender acrimony between practicing physicians and NPs. However, we lack empirical, descriptive data on how practicing professionals view NP independence in primary care., Objective: The aim of the present study was to explore and describe the attitudes about NP independence among physicians and NPs working in primary care., Design: A qualitative study based on the principles of grounded theory., Participants: Thirty primary care professionals in Missouri, USA, including 15 primary care physicians and 15 primary care NPs., Approach: Semi-structured, in-depth interviews, with data analysis guided by grounded theory., Key Results: Participants had perspectives that were not well represented by professional organizations or the media. Physicians were supportive of a wide variety of NP roles and comfortable with high levels of NP independence and autonomy. Physicians and NPs described prerequisites to NP independence that were complementary. Physicians generally believed that NPs needed some association with physicians for patient safety, and NPs preferred having a physician readily accessible as needed. The theme "knowing your limits" was important to both NPs and physicians regarding NP independence, and has not been described previously in the literature., Conclusions: NP and physician views about NP practice in primary care are not as divergent as their representative professional organizations and the news media would suggest. The significant agreement among NPs and physicians, and some of the nuances of their perspectives, supports recommendations that may reduce the perceived acrimony surrounding discussions of NP independent practice in primary care.
- Published
- 2017
- Full Text
- View/download PDF
43. Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [11C]ABP688 Positron-Emission Tomography (PET) Imaging.
- Author
-
DuBois JM, Rousset OG, Guiot MC, Hall JA, Reader AJ, Soucy JP, Rosa-Neto P, and Kobayashi E
- Subjects
- Adult, Carbon Radioisotopes pharmacokinetics, Cerebral Cortex drug effects, Cerebral Cortex metabolism, Female, Functional Laterality, Humans, Male, Malformations of Cortical Development pathology, Middle Aged, Oximes pharmacokinetics, Pyridines pharmacokinetics, Young Adult, Cerebral Cortex diagnostic imaging, Malformations of Cortical Development diagnostic imaging, Positron-Emission Tomography, Receptor, Metabotropic Glutamate 5 metabolism
- Abstract
Metabotropic glutamate receptor type 5 (mGluR5) abnormalities have been described in tissue resected from epilepsy patients with focal cortical dysplasia (FCD). To determine if these abnormalities could be identified in vivo, we investigated mGluR5 availability in 10 patients with focal epilepsy and an MRI diagnosis of FCD using positron-emission tomography (PET) and the radioligand [11C]ABP688. Partial volume corrected [11C]ABP688 binding potentials (BPND) were computed using the cerebellum as a reference region. Each patient was compared to homotopic cortical regions in 33 healthy controls using region-of-interest (ROI) and vertex-wise analyses. Reduced [11C]ABP688 BPND in the FCD was seen in 7/10 patients with combined ROI and vertex-wise analyses. Reduced FCD BPND was found in 4/5 operated patients (mean follow-up: 63 months; Engel I), of whom surgical specimens revealed FCD type IIb or IIa, with most balloon cells showing negative or weak mGluR5 immunoreactivity as compared to their respective neuropil and normal neurons at the border of resections. [11C]ABP688 PET shows for the first time in vivo evidence of reduced mGluR5 availability in FCD, indicating focal glutamatergic alterations in malformations of cortical development, which cannot be otherwise clearly demonstrated through resected tissue analyses., (© The Author 2016. Published by Oxford University Press.)
- Published
- 2016
- Full Text
- View/download PDF
44. Misconduct: Lessons from researcher rehab.
- Author
-
DuBois JM, Chibnall JT, Tait R, and Vander Wal J
- Subjects
- Animals, Decision Making, Empathy, Humans, Research Personnel ethics, Scientific Misconduct psychology, Scientific Misconduct statistics & numerical data, Stress, Psychological, Surveys and Questionnaires, Workload, Ethics, Research education, Research Personnel education, Research Personnel psychology, Scientific Misconduct classification
- Published
- 2016
- Full Text
- View/download PDF
45. Self-lubricating, low-friction, wear-resistant Al-based quasicrystalline coatings.
- Author
-
Silva Guedes de Lima BA, Medeiros Gomes R, Guedes de Lima SJ, Dragoe D, Barthes-Labrousse MG, Kouitat-Njiwa R, and Dubois JM
- Abstract
After gas atomization, a quasicrystalline powder based on aluminium was used to prepare a thick coating by high-velocity oxygen-fuel flame torch spraying. This layer was deposited on top of a bond-coat layer on a steel plate. A post-spraying annealing treatment turned the two layers to their stable state, a γ-brass crystal and an icosahedral quasicrystal, respectively. The projection parameters were selected in such a way that the coating behaved like a self-lubricating material, which offered very good wear resistance (duration of pin-on-disk tests superior to 5 km with negligible material loss) and low friction (µ ≤ 6% against sintered tungsten carbide), in contrast to the state of the art. This property was achieved thanks to, on the one hand, excellent bonding to the substrate via the bound coat, and on the other hand, presence at the boundaries between quasicrystalline flakes of a mixture of both threefold and fourfold coordinated carbon originating from spray processing. Application to hard materials used in mechanical devices is appealing, especially because soft, lubricating additives may not be needed, thus considerably increasing the lifetime of the devices and reducing waste of materials.
- Published
- 2016
- Full Text
- View/download PDF
46. Aligning objectives and assessment in responsible conduct of research instruction.
- Author
-
Antes AL and DuBois JM
- Abstract
Efforts to advance research integrity in light of concerns about misbehavior in research rely heavily on education in the responsible conduct of research (RCR). However, there is limited evidence for the effectiveness of RCR instruction as a remedy. Assessment is essential in RCR education if the research community wishes to expend the effort of instructors, students, and trainees wisely. This article presents key considerations that instructors and course directors must consider in aligning learning objectives with instructional methods and assessment measures, and it provides illustrative examples. Above all, in order for RCR educators to assess outcomes more effectively, they must align assessment to their learning objectives and attend to the validity of the measures used.
- Published
- 2014
- Full Text
- View/download PDF
47. Curricular priorities for business ethics in medical practice and research: recommendations from Delphi consensus panels.
- Author
-
DuBois JM, Kraus EM, Gursahani K, Mikulec A, and Bakanas E
- Subjects
- Biomedical Research ethics, Consensus, Delphi Technique, Educational Measurement, Female, Humans, Male, Practice Patterns, Physicians' ethics, United States, Biomedical Research education, Clinical Medicine education, Curriculum, Ethics, Business education, Practice Management, Medical ethics
- Abstract
Background: No published curricula in the area of medical business ethics exist. This is surprising given that physicians wrestle daily with business decisions and that professional associations, the Institute of Medicine, Health and Human Services, Congress, and industry have issued related guidelines over the past 5 years. To fill this gap, the authors aimed (1) to identify the full range of medical business ethics topics that experts consider important to teach, and (2) to establish curricular priorities through expert consensus., Methods: In spring 2012, the authors conducted an online Delphi survey with two heterogeneous panels of experts recruited in the United States. One panel focused on business ethics in medical practice (n = 14), and 1 focused on business ethics in medical research (n = 12)., Results: Panel 1 generated an initial list of 14 major topics related to business ethics in medical practice, and subsequently rated 6 topics as very important or essential to teach. Panel 2 generated an initial list of 10 major topics related to business ethics in medical research, and subsequently rated 5 as very important or essential. In both domains, the panel strongly recommended addressing problems that conflicts of interest can cause, legal guidelines, and the goals or ideals of the profession., Conclusions: The Bander Center for Medical Business Ethics at Saint Louis University will use the results of the Delphi panel to develop online curricular resources for each of the highest rated topics.
- Published
- 2014
- Full Text
- View/download PDF
48. Establishing the need and identifying goals for a curriculum in medical business ethics: a survey of students and residents at two medical centers in Missouri.
- Author
-
Kraus EM, Bakanas E, Gursahani K, and DuBois JM
- Subjects
- Missouri, Surveys and Questionnaires, Academic Medical Centers organization & administration, Curriculum, Ethics, Professional, Organizational Objectives
- Abstract
Background: In recent years, issues in medical business ethics (MBE), such as conflicts of interest (COI), Medicare fraud and abuse, and the structure and functioning of reimbursement systems, have received significant attention from the media and professional associations in the United States. As a result of highly publicized instances of financial interests altering physician decision-making, major professional organizations and government bodies have produced reports and guidelines to encourage self-regulation and impose rules to limit physician relationships with for-profit entities. Nevertheless, no published curricula exist in the area of MBE. This study aimed to establish a baseline level of knowledge and the educational goals medical students and residents prioritize in the area of MBE., Methods: 732 medical students and 380 residents at two academic medical centers in the state of Missouri, USA, completed a brief survey indicating their awareness of major MBE guidance documents, knowledge of key MBE research, beliefs about the goals of an education in MBE, and the areas of MBE they were most interested in learning more about., Results: Medical students and residents had little awareness of recent and major reports on MBE topics, and had minimal knowledge of basic MBE facts. Residents scored statistically better than medical students in both of these areas. Medical students and residents were in close agreement regarding the goals of an MBE curriculum. Both groups showed significant interest in learning more about MBE topics with an emphasis on background topics such as "the business aspects of medicine" and "health care delivery systems"., Conclusions: The content of major reports by professional associations and expert bodies has not trickled down to medical students and residents, yet both groups are interested in learning more about MBE topics. Our survey suggests potentially beneficial ways to frame and embed MBE topics into the larger framework of medical education.
- Published
- 2014
- Full Text
- View/download PDF
49. Friction and solid-solid adhesion on complex metallic alloys.
- Author
-
Dubois JM and Belin-Ferré E
- Abstract
The discovery in 1987 of stable quasicrystals in the Al-Cu-Fe system was soon exploited to patent specific coatings that showed reduced friction in ambient air against hard antagonists. Henceforth, it was possible to develop a number of applications, potential or commercially exploited to date, that will be alluded to in this topical review. A deeper understanding of the characteristics of complex metallic alloys (CMAs) may explain why material made of metals like Al, Cu and Fe offers reduced friction; low solid-solid adhesion came later. It is linked to the surface energy being significantly lower on those materials, in which translational symmetry has become a weak property, that is determined by the depth of the pseudo-gap at the Fermi energy. As a result, friction is anisotropic in CMAs that builds up according to the translation symmetry along one direction, but is aperiodic along the other two directions. A review is given in this article of the most salient data found along these lines during the past two decades or so.
- Published
- 2014
- Full Text
- View/download PDF
50. Assessing the need for a research ethics remediation program.
- Author
-
DuBois JM, Anderson EE, and Chibnall J
- Subjects
- Academies and Institutes, Data Collection, Ethics Committees, Research, Humans, Curriculum, Ethics, Research, Needs Assessment
- Abstract
With supplement funding to the Washington University CTSA, the Restoring Professionalism and Integrity in Research (RePAIR) program was developed at Saint Louis University to meet the remediation needs of institutions nationwide regarding investigators who violate research regulations. With the aim of determining the frequency and kinds of wrongdoing at leading research institutions in the United States, as well as institutional responses and levels of interest in a formal remediation program, an online questionnaire was distributed by email to a research integrity officer (RIO) and institutional review board (IRB) chair at all medical schools and comprehensive doctoral institutions in the United States (N = 194). One hundred sixty-one individuals responded (44%) representing 66% of institutions. For those institutions that had both RIOs and IRB chairs responding, 96% had investigated at least one case over the past 2 years; the modal individual response was 3-5 cases, with a range from 0 to more than 16 cases. The most common forms of wrongdoing were violations of procedure, informed consent, research integrity (fabrication, falsification, plagiarism), privacy, and conflict of interest policies. Most RIOs and IRB chairs expressed interest in the RePAIR program, despite concerns about costs and faculty resistance., (© 2013 Wiley Periodicals, Inc.)
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.